Thyroid Adenoma

Thyroid adenoma is a benign, encapsulated neoplasm arising from the follicular epithelial cells of the thyroid gland. It is the most common thyroid tumor in cats, where it typically manifests as a functional adenoma causing hyperthyroidism. In dogs, thyroid adenomas are rare and usually non-functional, often discovered incidentally. The tumor is characterized by well-differentiated follicular cells that may form microfollicular, macrofollicular, or trabecular patterns, with minimal cellular atypia and no capsular or vascular invasion. Thyroid adenomas are distinct from thyroid carcinomas by their lack of invasive growth and metastatic potential. They can be solitary or multiple, and in cats, bilateral involvement is common (approximately 70% of cases). The clinical significance of thyroid adenomas lies primarily in their excessive production of thyroid hormones, leading to a multisystemic thyrotoxic state.

The exact etiology of thyroid adenomas is not fully understood, but several factors have been implicated. In cats, chronic exposure to dietary goitrogens, such as those found in certain commercial cat foods (e.g., isoflavones from soy, phthalates from can linings), has been proposed as a contributing factor. Additionally, genetic mutations in the TSH receptor (TSHR) or G-protein alpha subunit (GNAS) genes have been identified in some feline thyroid adenomas, leading to constitutive activation of the cAMP signaling pathway and autonomous hormone production. Environmental factors, including exposure to iodine, have also been suggested, though evidence is inconclusive. In dogs, thyroid adenomas are often incidental findings and may arise from chronic TSH stimulation due to hypothyroidism, but this association is not well-established. No viral or bacterial etiology has been identified.

Thyroid adenomas are most commonly diagnosed in middle-aged to older cats, with a median age of 13 years (range 6-20 years). There is no significant breed or sex predisposition in cats, although some studies suggest a higher incidence in domestic shorthair cats. In dogs, thyroid adenomas are rare, accounting for less than 5% of all canine thyroid tumors, and are typically found in older dogs (mean age 10 years). No breed predilection is noted, but some reports suggest a higher incidence in beagles, boxers, and golden retrievers. The incidence of feline hyperthyroidism, primarily due to adenomas, has increased since the 1970s, possibly due to dietary changes and environmental factors. Geographic variation exists, with higher prevalence in North America and Europe compared to other regions.

Thyroid adenomas are benign proliferations of thyroid follicular cells that autonomously produce thyroid hormones (T3 and T4) independent of normal feedback regulation by thyroid-stimulating hormone (TSH). This autonomy results from somatic mutations that activate the TSH receptor signaling pathway, leading to increased cAMP production and subsequent thyroid hormone synthesis and secretion. The excessive circulating thyroid hormones cause a hypermetabolic state, affecting nearly every organ system. Thyroid hormones increase basal metabolic rate, enhance catecholamine sensitivity, and stimulate protein and carbohydrate metabolism. Clinically, this manifests as weight loss despite polyphagia, tachycardia, hypertension, and hyperactivity. Chronic thyrotoxicosis can lead to myocardial hypertrophy, arrhythmias, and congestive heart failure. Additionally, increased bone resorption can cause hypercalcemia, and increased glomerular filtration rate may exacerbate pre-existing renal disease. In dogs, non-functional adenomas do not produce hormones and are often asymptomatic, but large masses can cause local compressive signs such as dysphagia, dyspnea, or Horner's syndrome.

Predisposing factors for thyroid adenomas include advanced age, as the incidence increases with age in both cats and dogs. In cats, dietary factors such as consumption of canned food, particularly those containing high levels of iodine or goitrogens, have been implicated. Genetic predisposition is suggested by the presence of activating mutations in TSHR and GNAS genes. Chronic TSH stimulation, as seen in hypothyroidism, may predispose dogs to adenoma formation, though this is speculative. Environmental factors, including exposure to certain chemicals (e.g., flame retardants, phthalates), have been proposed but not definitively proven. No sex predilection is consistently reported.

Clinical signs of thyroid adenomas are primarily due to hyperthyroidism in cats and local mass effects in dogs. In cats, common signs include weight loss despite a good or increased appetite, polyphagia, polydipsia, polyuria, vomiting, diarrhea, hyperactivity, and aggression. Physical examination findings may include a palpable thyroid nodule (goiter), tachycardia, cardiac murmur, and unkempt hair coat. In advanced cases, signs of congestive heart failure (dyspnea, crackles) and hypertension (retinal detachment, blindness) may be present. In dogs, non-functional adenomas are often asymptomatic, but large masses can cause cervical swelling, dysphagia, dysphonia, coughing, and respiratory distress. If the adenoma is functional (rare), signs similar to feline hyperthyroidism may occur, including weight loss, polyphagia, and tachycardia.

Differential diagnoses for thyroid adenoma include: 1) Thyroid carcinoma: Malignant tumor that may be functional or non-functional; distinguished by histopathology showing capsular or vascular invasion, cellular atypia, and metastasis (especially to regional lymph nodes and lungs). 2) Thyroid cyst: Fluid-filled lesion, often benign; diagnosed via ultrasound and cytology. 3) Thyroiditis: Inflammation of the thyroid gland, which can cause transient hyperthyroidism; diagnosed by cytology showing inflammatory cells and possibly infectious agents. 4) Ectopic thyroid tissue: Rare, but can present as a mass in the thoracic cavity or other locations; diagnosed by scintigraphy or histopathology. 5) Lymphadenopathy: Enlarged cervical lymph nodes (e.g., due to lymphoma or infection) can mimic a thyroid mass; differentiated by location and cytology. 6) Salivary gland mucocele: A cystic swelling in the cervical region; diagnosed by aspiration of mucinous fluid. 7) Branchial cleft cyst: Congenital cyst in the neck; diagnosed by imaging and histopathology. 8) Parathyroid adenoma or hyperplasia: Can cause hypercalcemia and may be associated with a cervical mass; differentiated by serum calcium and PTH levels. 9) Hypothyroidism: In dogs, hypothyroidism can cause weight gain and lethargy, but thyroid adenomas are usually non-functional; thyroid hormone levels are low. 10) Other neoplasms: Such as chemodectoma or carotid body tumor, which can present as a cervical mass; diagnosed by histopathology.

The diagnostic approach for suspected thyroid adenoma begins with a thorough history and physical examination, including palpation of the cervical region. In cats with suspected hyperthyroidism, baseline serum total T4 concentration is the initial screening test; if elevated, hyperthyroidism is confirmed. If T4 is within the upper normal range or borderline, additional testing such as free T4 by equilibrium dialysis or TSH measurement may be helpful. In dogs with a cervical mass, fine-needle aspiration (FNA) for cytology is often the first step to differentiate adenoma from carcinoma. Imaging, including cervical radiography, ultrasonography, and advanced imaging (CT or MRI), is useful to assess the size, extent, and invasiveness of the mass. Thyroid scintigraphy (using technetium-99m pertechnetate) can differentiate functional thyroid tissue from non-functional masses and detect ectopic thyroid tissue. Definitive diagnosis of adenoma versus carcinoma requires histopathology after surgical excision or biopsy. In cats, a complete blood count, serum biochemistry profile, urinalysis, and blood pressure measurement are essential to evaluate for concurrent diseases, especially renal and cardiac disease.

In cats with functional thyroid adenomas, the most consistent laboratory finding is elevated serum total T4 concentration. Free T4 by equilibrium dialysis may be elevated in cases with normal total T4. Serum TSH is typically suppressed. Other biochemical abnormalities may include elevated liver enzymes (ALT, ALP), particularly ALP, due to the hypermetabolic state. Mild hypercalcemia may occur due to increased bone resorption. In dogs with non-functional adenomas, laboratory findings are usually unremarkable unless the mass causes local complications. If the adenoma is functional, similar changes to cats may be seen. Complete blood count may show a stress leukogram (neutrophilia, lymphopenia, eosinopenia) in hyperthyroid cats. Urinalysis may reveal low urine specific gravity due to polyuria, and proteinuria may be present if concurrent renal disease exists. Blood pressure measurement often reveals hypertension in hyperthyroid cats.

Radiography: In cats, cervical radiographs may show a soft tissue mass in the ventral neck, but this is not sensitive. Thoracic radiographs are important to evaluate for cardiomegaly and congestive heart failure in hyperthyroid cats. In dogs, cervical radiographs can reveal a large mass causing tracheal deviation or compression. Ultrasonography: Thyroid ultrasonography is useful to characterize the mass (solid vs. cystic), assess echogenicity, and evaluate the contralateral lobe. In cats, adenomas typically appear as well-defined, hypoechoic nodules with increased vascularity on Doppler. In dogs, adenomas are often hypoechoic and may be difficult to distinguish from carcinomas. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): These modalities provide detailed anatomical information, including the extent of the mass, invasion into surrounding tissues, and lymph node involvement. They are particularly useful in dogs for surgical planning. Thyroid Scintigraphy: This is the gold standard for identifying functional thyroid tissue. It can differentiate between adenoma and carcinoma based on uptake patterns, and it can detect ectopic thyroid tissue. Echocardiography: In hyperthyroid cats, echocardiography may reveal concentric hypertrophy of the left ventricle, which can regress after treatment.

Fine-needle aspiration (FNA) cytology of thyroid adenomas typically shows clusters of follicular epithelial cells with abundant cytoplasm and round nuclei, often with colloid material in the background. However, cytology cannot reliably distinguish adenoma from carcinoma, as both may appear similar. Histopathology is the definitive diagnostic method. On histologic examination, adenomas are well-circumscribed, encapsulated masses composed of follicular cells arranged in microfollicular, macrofollicular, or trabecular patterns. The cells are uniform, with minimal nuclear atypia and rare mitotic figures. There is no capsular or vascular invasion. In contrast, carcinomas show invasion of the capsule or blood vessels, cellular pleomorphism, and increased mitotic activity. Immunohistochemistry may be used to differentiate thyroid origin (e.g., thyroglobulin positivity) and to assess proliferation markers (Ki-67).

Treatment of thyroid adenomas depends on the species and whether the tumor is functional. In cats with hyperthyroidism, therapeutic options include: 1) Medical management with antithyroid drugs (e.g., methimazole) to control hormone levels; 2) Surgical thyroidectomy, which is curative if both lobes are removed; 3) Radioactive iodine (I-131) therapy, which is the treatment of choice for many cases due to its high success rate and minimal side effects; 4) Dietary management with a low-iodine diet (e.g., Hill's y/d) to reduce hormone synthesis. In dogs with non-functional adenomas, surgical excision is often recommended if the mass is large or causing clinical signs. If the adenoma is functional, treatment options are similar to those in cats, but medical management with methimazole is less commonly used due to the rarity. Supportive care includes management of hypertension, cardiac disease, and renal disease in hyperthyroid cats. In all cases, regular monitoring of thyroid hormone levels and clinical status is essential.

The prognosis for thyroid adenomas is generally excellent, especially in cats with hyperthyroidism treated with radioactive iodine or surgery, as these are curative. The median survival time for cats with hyperthyroidism treated with I-131 is over 2 years, with many cats living for several more years. However, the prognosis can be guarded if there is concurrent renal disease, cardiac disease, or other comorbidities. In dogs, the prognosis for non-functional adenomas is excellent after surgical excision, with a low recurrence rate. Functional adenomas in dogs are rare, but if treated appropriately, the prognosis is also good. Negative prognostic indicators include the presence of metastatic disease (which would indicate carcinoma), severe concurrent illness, and poor response to treatment.

Follow-up care for thyroid adenomas depends on the treatment modality. For cats treated with radioactive iodine, thyroid hormone levels should be checked at 1, 3, 6, and 12 months post-treatment, then annually. For cats on medical management, T4 levels should be monitored every 2-4 weeks until stable, then every 3-6 months. Blood pressure and renal function should be monitored regularly. For cats undergoing surgery, thyroid hormone levels should be checked post-operatively to ensure resolution of hyperthyroidism. For dogs with non-functional adenomas, follow-up imaging (ultrasound or CT) may be recommended every 6-12 months to monitor for recurrence. In all cases, owners should be educated on the signs of hyperthyroidism or hypothyroidism, as treatment may lead to iatrogenic hypothyroidism, requiring thyroid hormone supplementation.

Pearls: 1) In cats, a palpable thyroid nodule is a strong indicator of hyperthyroidism, but not all cats with hyperthyroidism have a palpable nodule. 2) Thyroid scintigraphy is invaluable for detecting ectopic thyroid tissue and for differentiating adenoma from carcinoma. 3) In cats with hyperthyroidism, always evaluate renal function before initiating treatment, as treatment can unmask underlying chronic kidney disease. 4) Radioactive iodine therapy is the preferred treatment for cats with bilateral disease or ectopic thyroid tissue. Pitfalls: 1) Relying solely on total T4 to diagnose hyperthyroidism can miss early cases; free T4 and TSH should be considered. 2) In dogs, cytology cannot reliably distinguish adenoma from carcinoma; histopathology is essential. 3) In cats, medical management with methimazole can cause gastrointestinal upset and facial pruritus; monitor for side effects. 4) Do not overlook concurrent diseases such as hypertension and cardiac disease in hyperthyroid cats, as they can affect treatment outcomes.

For feline hyperthyroidism due to thyroid adenoma, the primary medical therapy is methimazole (Tapazole). The initial dosage is 2.5 mg per cat orally every 12 hours. After 2-3 weeks, the dose can be increased to 5 mg every 12 hours if needed, based on T4 levels. The maximum recommended dose is 10 mg every 12 hours. Methimazole should be given with food to reduce gastrointestinal side effects. Alternative antithyroid drugs include carbimazole, which is converted to methimazole in the body; the dosage is similar. For dogs with functional thyroid adenomas, methimazole can be used at a dosage of 5-15 mg per dog orally every 8-12 hours, but this is rarely needed. Beta-blockers such as propranolol (0.2-1 mg/kg orally every 8 hours) or atenolol (0.25-1 mg/kg orally every 12 hours) may be used to control tachycardia and hypertension in hyperthyroid patients. For management of hypertension, amlodipine (0.625-1.25 mg per cat orally every 24 hours) is commonly used. In cases of congestive heart failure, furosemide (1-2 mg/kg IV or SC, then 1-2 mg/kg orally every 8-12 hours) and pimobendan (0.25-0.3 mg/kg orally every 12 hours) may be indicated. All dosages should be adjusted based on renal and hepatic function, and drug interactions should be considered, especially with antithyroid drugs and beta-blockers.

The management of feline hyperthyroidism has been extensively studied. A landmark study by Peterson et al. (1983) established the efficacy of methimazole in controlling hyperthyroidism. Radioactive iodine therapy has been shown to be highly effective, with a success rate of over 95% in a single dose, as reported by Peterson and Becker (1995). A study by Norsworthy et al. (2002) demonstrated that dietary iodine restriction can effectively manage hyperthyroidism in cats. The ACVIM consensus statement on the diagnosis and treatment of feline hyperthyroidism (2016) provides evidence-based guidelines, recommending thyroid scintigraphy for atypical cases and emphasizing the importance of monitoring renal function. In dogs, thyroid adenomas are rare, and most literature consists of case reports. A study by Liptak et al. (2008) reviewed canine thyroid tumors and noted that adenomas have an excellent prognosis after surgical excision. Overall, the evidence supports the use of radioactive iodine as the preferred treatment for feline hyperthyroidism due to its safety and efficacy, while medical management is a viable alternative for owners who prefer non-invasive options.